Sofie H Mooij1, Daniëla K van Santen, Ronald B Geskus, Marianne A B van der Sande, Roel A Coutinho, Ineke G Stolte, Peter J F Snijders, Chris J L M Meijer, Arjen G C L Speksnijder, Henry J C de Vries, Audrey J King, Arne van Eeden, Maarten F Schim van der Loeff. 1. aDepartment of Infectious Diseases, Public Health Service AmsterdambDepartment of Internal Medicine, Center for Infection and Immunity Amsterdam (CINIMA)cDepartment of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, AmsterdamdCentre for Infectious Disease Control, National Institute for Public Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu, RIVM), BilthoveneJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, UtrechtfDepartment of Pathology, Vrije Universiteit-University Medical Center (VUmc)gDepartment of Dermatology, Academic Medical CenterhDepartment of Internal Medicine, Jan van Goyen Medical Center, Amsterdam, The Netherlands.*Present address: DC Klinieken Oud Zuid, Amsterdam, The Netherlands.
Abstract
OBJECTIVES: A large portion of anogenital cancers is caused by high-risk human papillomavirus (hrHPV) infections, which are especially common in HIV-infected men. We aimed to compare the incidence and clearance of anal and penile hrHPV infection between HIV-infected and HIV-negative MSM. DESIGN: Analyses of longitudinal data from a prospective cohort study. METHODS: MSM aged 18 years or older were recruited in Amsterdam, the Netherlands, and followed-up semi-annually for 24 months. At each visit, participants completed risk-factor questionnaires. Anal and penile self-samples were tested for HPV DNA using the SPF10-PCR DEIA/LiPA25 system. Effects on incidence and clearance rates were quantified via Poisson regression, using generalized estimating equations to correct for multiple hrHPV types. RESULTS: Seven hundred and fifty MSM with a median age of 40 years (interquartile 35-48) were included in the analyses, of whom 302 (40%) were HIV-infected. The incidence rates of hrHPV were significantly higher in HIV-infected compared with HIV-negative MSM [adjusted incidence rate ratio (aIRR) 1.6; 95% confidence interval (CI) 1.3-2.1 for anal and aIRR 1.4; 95%CI 1.0-2.1 for penile infection]. The clearance rate of hrHPV was significantly lower for anal [adjusted clearance rate ratio (aCRR) 0.7; 95%CI 0.6-0.9], but not for penile infection (aCRR 1.3; 95%CI 1.0-1.7). HrHPV incidence or clearance did not differ significantly by nadir CD4 cell count. CONCLUSION: Increased anal and penile hrHPV incidence rates and decreased anal hrHPV clearance rates were found in HIV-infected compared with HIV-negative MSM, after adjusting for sexual behavior. Our findings suggest an independent effect of HIV infection on anal hrHPV infections.
OBJECTIVES: A large portion of anogenital cancers is caused by high-risk human papillomavirus (hrHPV) infections, which are especially common in HIV-infectedmen. We aimed to compare the incidence and clearance of anal and penile hrHPV infection between HIV-infected and HIV-negative MSM. DESIGN: Analyses of longitudinal data from a prospective cohort study. METHODS: MSM aged 18 years or older were recruited in Amsterdam, the Netherlands, and followed-up semi-annually for 24 months. At each visit, participants completed risk-factor questionnaires. Anal and penile self-samples were tested for HPV DNA using the SPF10-PCR DEIA/LiPA25 system. Effects on incidence and clearance rates were quantified via Poisson regression, using generalized estimating equations to correct for multiple hrHPV types. RESULTS: Seven hundred and fifty MSM with a median age of 40 years (interquartile 35-48) were included in the analyses, of whom 302 (40%) were HIV-infected. The incidence rates of hrHPV were significantly higher in HIV-infected compared with HIV-negative MSM [adjusted incidence rate ratio (aIRR) 1.6; 95% confidence interval (CI) 1.3-2.1 for anal and aIRR 1.4; 95%CI 1.0-2.1 for penile infection]. The clearance rate of hrHPV was significantly lower for anal [adjusted clearance rate ratio (aCRR) 0.7; 95%CI 0.6-0.9], but not for penile infection (aCRR 1.3; 95%CI 1.0-1.7). HrHPV incidence or clearance did not differ significantly by nadir CD4 cell count. CONCLUSION: Increased anal and penile hrHPV incidence rates and decreased anal hrHPV clearance rates were found in HIV-infected compared with HIV-negative MSM, after adjusting for sexual behavior. Our findings suggest an independent effect of HIV infection on anal hrHPV infections.
Authors: Fengyi Jin; Claire M Vajdic; Matthew Law; Janaki Amin; Marina van Leeuwen; Skye McGregor; I Mary Poynten; David J Templeton; Andrew E Grulich Journal: AIDS Date: 2019-07-01 Impact factor: 4.177
Authors: Rebecca G Nowak; Søren M Bentzen; Lisa M Schumaker; Nicholas P Ambulos; Nicaise Ndembi; Wuese Dauda; Andrew Mitchell; Trevor J Mathias; Trevor A Crowell; Stefan D Baral; William A Blattner; Manhattan E Charurat; Joel M Palefsky; Kevin J Cullen Journal: Sex Transm Dis Date: 2022-04-01 Impact factor: 2.830
Authors: Kayo Fujimoto; Aditya Khanna; Alan G Nyitray; Jacky Kuo; Jing Zhao; Lu-Yu Hwang; Elizabeth Chiao; Anna R Giuliano; John A Schneider Journal: Sex Transm Infect Date: 2022-02-19 Impact factor: 4.199
Authors: Alan G Nyitray; Kayo Fujimoto; Jing Zhao; Anna R Giuliano; John A Schneider; Lu-Yu Hwang Journal: J Infect Dis Date: 2018-02-14 Impact factor: 5.226
Authors: Eleanor M King; Soonita Oomeer; Richard Gilson; Andrew Copas; Simon Beddows; Kate Soldan; Mark Jit; W John Edmunds; Pam Sonnenberg Journal: PLoS One Date: 2016-07-06 Impact factor: 3.240
Authors: Janneke C M Heijne; Geneviève A F S van Liere; Christian J P A Hoebe; Johannes A Bogaards; Birgit H B van Benthem; Nicole H T M Dukers-Muijrers Journal: Sex Transm Infect Date: 2016-12-16 Impact factor: 3.519
Authors: Katharine J Looker; Minttu M Rönn; Patrick M Brock; Marc Brisson; Melanie Drolet; Philippe Mayaud; Marie-Claude Boily Journal: J Int AIDS Soc Date: 2018-06 Impact factor: 5.396
Authors: Evy Yunihastuti; Nipat Teeratakulpisarn; Wifanto Saditya Jeo; Hanny Nilasari; Lisnawati Rachmadi; I Ketut Agus Somia; Made Dewi Dian Sukmawati; Komang Agus Trisna Amijaya; Ilias A Yee; Nany Hairunisa; Piranun Hongchookiat; Deondara Trachunthong; Tippawan Pankam; Siriporn Nonenoy; Reshmie Ramautarsing; Iskandar Azwa; Tuti P Merati; Praphan Phanuphak; Nittaya Phanuphak; Joel M Palefsky Journal: AIDS Date: 2020-11-01 Impact factor: 4.632
Authors: Attila T Lorincz; Mayura Nathan; Caroline Reuter; Rhian Warman; Mohamed A Thaha; Michael Sheaff; Natasa Vasiljevic; Amar Ahmad; Jack Cuzick; Peter Sasieni Journal: Oncotarget Date: 2017-05-18